X

pharma stocks

Thailand legalizes medical use of cannabis, opens up a new region for pot stocks

After Uruguay and Canada, Thailand has now amended its drug law to legalize marijuana for medical purposes. However, unlike the…

Mallinckrodt soars 10% on strong Q3

Pharmaceutical company Mallinckrodt plc (MNK) Tuesday reported third-quarter results that topped analysts’ estimates, sending its shares up 10% during pre-market…

Abbott posts strong Q3 results, narrows full year outlook

Pharmaceutical giant Abbott Laboratories (ABT) delivered a 12% increase in third-quarter revenue to $7.7 billion, helped by a 43% increase…

Pharmaceuticals unit lifts Johnson & Johnson results in Q3

Medical devices giant Johnson & Johnson (JNJ) reported higher revenue and income in Q3, driven by strong sales of pharmaceuticals…

Three pharma stocks to buy and hold this quarter

Healthcare and pharma companies hold a lot of promise in the present landscape, where most countries have high aging demographics.…

Johnson & Johnson under the scanner in India over “faulty” hip replacement devices

An experts’ panel framed by India’s Ministry of Health has found that Johnson & Johnson (JNJ) suppressed facts relating to…

Eylea lifts Regeneron Q2 earnings

Regeneron Pharmaceuticals Thursday reported better-than-expected second quarter earnings of $5.45 per share on a revenue of $1.6 billion. Revenue for…

AbbVie’s elagolix meet phase III trial target

Among the pharma stocks, AbbVie (ABBV) is a company that has got an impressive reputation for growing demand for its…